Abstract

Aims/hypothesisInsulin resistance (IR) links obesity to type 2 diabetes. The aim of this study was to explore whether white adipose tissue (WAT) epigenetic dysregulation is associated with systemic IR by genome-wide CG dinucleotide (CpG) methylation and gene expression profiling in WAT from insulin-resistant and insulin-sensitive women. A secondary aim was to determine whether the DNA methylation signature in peripheral blood mononuclear cells (PBMCs) reflects WAT methylation and, if so, can be used as a marker for systemic IR.MethodsFrom 220 obese women, we selected a total of 80 individuals from either of the extreme ends of the distribution curve of HOMA-IR, an indirect measure of systemic insulin sensitivity. Genome-wide transcriptome and DNA CpG methylation profiling by array was performed on subcutaneous (SAT) and visceral (omental) adipose tissue (VAT). CpG methylation in PBMCs was assayed in the same cohort.ResultsThere were 647 differentially expressed genes (false discovery rate [FDR] 10%) in SAT, all of which displayed directionally consistent associations in VAT. This suggests that IR is associated with dysregulated expression of a common set of genes in SAT and VAT. The average degree of DNA methylation did not differ between the insulin-resistant and insulin-sensitive group in any of the analysed tissues/cells. There were 223 IR-associated genes in SAT containing a total of 336 nominally significant differentially methylated sites (DMS). The 223 IR-associated genes were over-represented in pathways related to integrin cell surface interactions and insulin signalling and included COL5A1, GAB1, IRS2, PFKFB3 and PTPRJ. In VAT there were a total of 51 differentially expressed genes (FDR 10%); 18 IR-associated genes contained a total of 29 DMS.Conclusions/interpretationIn individuals discordant for insulin sensitivity, the average DNA CpG methylation in SAT and VAT is similar, although specific genes, particularly in SAT, display significantly altered expression and DMS in IR, possibly indicating that epigenetic regulation of these genes influences metabolism.Electronic supplementary materialThe online version of this article (doi:10.1007/s00125-016-4074-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

Highlights

  • The impaired ability of insulin to induce cellular responses is a pathophysiological mechanism that links obesity to metabolic disorders such as type 2 diabetes and cardiovascular disease [1]

  • Other pathways implicated in systemic Insulin resistance (IR) include low-grade inflammation in white adipose tissue (WAT) [6]

  • The aim of this study was to explore whether systemic IR is associated with epigenetic dysregulation of WAT, determined by genome-wide CpG methylation and gene expression profiling in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT)

Read more

Summary

Introduction

The impaired ability of insulin to induce cellular responses (i.e. insulin resistance [IR]) is a pathophysiological mechanism that links obesity to metabolic disorders such as type 2 diabetes and cardiovascular disease [1]. Both genetic and epigenetic factors are implicated in the development of systemic IR [2], which may be characterised by elevated circulating levels of insulin in the fasting state despite normal or elevated glucose levels. Other pathways implicated in systemic IR include low-grade inflammation in white adipose tissue (WAT) [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call